Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis. (Q47884689)
Jump to navigation
Jump to search
scientific article published in May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis. |
scientific article published in May 2009 |
Statements
1 reference
Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis. (English)
1 reference
1 reference
Caroline Coisne
1 reference
Wenxian Mao
1 reference
1 May 2009
1 reference
1 reference
182
1 reference
10
1 reference
5909-5913
1 reference
Identifiers
1 reference
1 reference